NORTH CAROLINA

pride-hd

Winston-Salem, NC

Wake Forest University School of Medicine

Contact: Christine O'Neill

336-716-8611

coneill@wakehealth.edu

ARC-HD (Roll-over and switch studies)

Durham, NC
Duke University
Contact: Peggy Perry-Trice
919-684-0865
peggy-perrytrice@duke.edu

First HD

Durham, NC
Duke University
Contact: Peggy Perry-Trice
919-684-0865
peggy-perrytrice@duke.edu

CREST-E (Creatine Phase 3)

Durham, North Carolina

Duke University

Peggy Perry-Trice

919-684-0865

peggy.perrytrice@duke.edu

 

Wake Forest University School of Medicine

Winston-Salem, NC

Study Coordinator: Christine O'Neill

336-716-8611

coneill@wakehealth.edu

 

Enroll-HD


Duke University Medical Center


Duke Movement Disorders Clinic
932 Morreene Road
Durham, NC 27705

919-684-0865

Scott Burton PI,   scott007@mc.duke.edu

Peggy Perry-Trice SC,   peggy.perrytrice@duke.edu

 

Wake Forest University School of Medicine

Winston-Salem, NC

Study Coordinator: Christine O'Neill

336-716-8611

Frances Walker, PI
fwalker@wakehealth.edu

Christine O'Neill, SC
coneill@wakehealth.edu

 

pfizer pde10a inhibitor (amaryllis study)

Wake Forest University School of Medicine

Winston-Salem, NC

Study Coordinator: Christine O'Neill

336-716-8611

coneill@wakehealth.edu

 

(For a description of the Trial click on the Trial Name)